Index
1 Remicade (infliximab) Drug Market Overview
1.1 Product Overview and Scope of Remicade (infliximab) Drug
1.2 Remicade (infliximab) Drug Segment by Type
1.2.1 Global Remicade (infliximab) Drug Market Value Comparison by Type (2024-2030)
1.2.2 Brands Drugs
1.2.3 Generic Drugs
1.3 Remicade (infliximab) Drug Segment by Application
1.3.1 Global Remicade (infliximab) Drug Market Value by Application: (2024-2030)
1.3.2 Crohn's Disease
1.3.3 Pediatric Crohn's Disease
1.3.4 Ulcerative Colitis
1.3.5 Pediatric Ulcerative Colitis
1.3.6 Other
1.4 Global Remicade (infliximab) Drug Market Size Estimates and Forecasts
1.4.1 Global Remicade (infliximab) Drug Revenue 2019-2030
1.4.2 Global Remicade (infliximab) Drug Sales 2019-2030
1.4.3 Global Remicade (infliximab) Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Remicade (infliximab) Drug Market Competition by Manufacturers
2.1 Global Remicade (infliximab) Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Remicade (infliximab) Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Remicade (infliximab) Drug Average Price by Manufacturers (2019-2024)
2.4 Global Remicade (infliximab) Drug Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Remicade (infliximab) Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Remicade (infliximab) Drug, Product Type & Application
2.7 Remicade (infliximab) Drug Market Competitive Situation and Trends
2.7.1 Remicade (infliximab) Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Remicade (infliximab) Drug Players Market Share by Revenue
2.7.3 Global Remicade (infliximab) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Remicade (infliximab) Drug Retrospective Market Scenario by Region
3.1 Global Remicade (infliximab) Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Remicade (infliximab) Drug Global Remicade (infliximab) Drug Sales by Region: 2019-2030
3.2.1 Global Remicade (infliximab) Drug Sales by Region: 2019-2024
3.2.2 Global Remicade (infliximab) Drug Sales by Region: 2025-2030
3.3 Global Remicade (infliximab) Drug Global Remicade (infliximab) Drug Revenue by Region: 2019-2030
3.3.1 Global Remicade (infliximab) Drug Revenue by Region: 2019-2024
3.3.2 Global Remicade (infliximab) Drug Revenue by Region: 2025-2030
3.4 North America Remicade (infliximab) Drug Market Facts & Figures by Country
3.4.1 North America Remicade (infliximab) Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Remicade (infliximab) Drug Sales by Country (2019-2030)
3.4.3 North America Remicade (infliximab) Drug Revenue by Country (2019-2030)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Remicade (infliximab) Drug Market Facts & Figures by Country
3.5.1 Europe Remicade (infliximab) Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Remicade (infliximab) Drug Sales by Country (2019-2030)
3.5.3 Europe Remicade (infliximab) Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Remicade (infliximab) Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Remicade (infliximab) Drug Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Remicade (infliximab) Drug Sales by Country (2019-2030)
3.6.3 Asia Pacific Remicade (infliximab) Drug Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Remicade (infliximab) Drug Market Facts & Figures by Country
3.7.1 Latin America Remicade (infliximab) Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Remicade (infliximab) Drug Sales by Country (2019-2030)
3.7.3 Latin America Remicade (infliximab) Drug Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Remicade (infliximab) Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Remicade (infliximab) Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Remicade (infliximab) Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Remicade (infliximab) Drug Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Remicade (infliximab) Drug Sales by Type (2019-2030)
4.1.1 Global Remicade (infliximab) Drug Sales by Type (2019-2024)
4.1.2 Global Remicade (infliximab) Drug Sales by Type (2025-2030)
4.1.3 Global Remicade (infliximab) Drug Sales Market Share by Type (2019-2030)
4.2 Global Remicade (infliximab) Drug Revenue by Type (2019-2030)
4.2.1 Global Remicade (infliximab) Drug Revenue by Type (2019-2024)
4.2.2 Global Remicade (infliximab) Drug Revenue by Type (2025-2030)
4.2.3 Global Remicade (infliximab) Drug Revenue Market Share by Type (2019-2030)
4.3 Global Remicade (infliximab) Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Remicade (infliximab) Drug Sales by Application (2019-2030)
5.1.1 Global Remicade (infliximab) Drug Sales by Application (2019-2024)
5.1.2 Global Remicade (infliximab) Drug Sales by Application (2025-2030)
5.1.3 Global Remicade (infliximab) Drug Sales Market Share by Application (2019-2030)
5.2 Global Remicade (infliximab) Drug Revenue by Application (2019-2030)
5.2.1 Global Remicade (infliximab) Drug Revenue by Application (2019-2024)
5.2.2 Global Remicade (infliximab) Drug Revenue by Application (2025-2030)
5.2.3 Global Remicade (infliximab) Drug Revenue Market Share by Application (2019-2030)
5.3 Global Remicade (infliximab) Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 J & J
6.1.1 J & J Corporation Information
6.1.2 J & J Description and Business Overview
6.1.3 J & J Remicade (infliximab) Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 J & J Remicade (infliximab) Drug Product Portfolio
6.1.5 J & J Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Remicade (infliximab) Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Remicade (infliximab) Drug Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Celltrion Healthcare
6.3.1 Celltrion Healthcare Corporation Information
6.3.2 Celltrion Healthcare Description and Business Overview
6.3.3 Celltrion Healthcare Remicade (infliximab) Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Celltrion Healthcare Remicade (infliximab) Drug Product Portfolio
6.3.5 Celltrion Healthcare Recent Developments/Updates
6.4 Epirus Biopharmaceuticals
6.4.1 Epirus Biopharmaceuticals Corporation Information
6.4.2 Epirus Biopharmaceuticals Description and Business Overview
6.4.3 Epirus Biopharmaceuticals Remicade (infliximab) Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Epirus Biopharmaceuticals Remicade (infliximab) Drug Product Portfolio
6.4.5 Epirus Biopharmaceuticals Recent Developments/Updates
6.5 Samsung Bioepsis
6.5.1 Samsung Bioepsis Corporation Information
6.5.2 Samsung Bioepsis Description and Business Overview
6.5.3 Samsung Bioepsis Remicade (infliximab) Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Samsung Bioepsis Remicade (infliximab) Drug Product Portfolio
6.5.5 Samsung Bioepsis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Remicade (infliximab) Drug Industry Chain Analysis
7.2 Remicade (infliximab) Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Remicade (infliximab) Drug Production Mode & Process
7.4 Remicade (infliximab) Drug Sales and Marketing
7.4.1 Remicade (infliximab) Drug Sales Channels
7.4.2 Remicade (infliximab) Drug Distributors
7.5 Remicade (infliximab) Drug Customers
8 Remicade (infliximab) Drug Market Dynamics
8.1 Remicade (infliximab) Drug Industry Trends
8.2 Remicade (infliximab) Drug Market Drivers
8.3 Remicade (infliximab) Drug Market Challenges
8.4 Remicade (infliximab) Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer